|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | ||||||||||||
| Deferred offering costs | ||||||||||||
| Assets: | ||||||||||||
| Cash | ||||||||||||
| Prepaid expenses | ||||||||||||
| Total current assets | ||||||||||||
| Investment in Qenta Equity, at fair value | ||||||||||||
| Investments held in Trust Account | ||||||||||||
| Total Assets | ||||||||||||
| Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit: | ||||||||||||
| Accrued offering costs | ||||||||||||
| Promissory Note – Related Party | ||||||||||||
| Accounts payable | ||||||||||||
| Convertible note - related party | ||||||||||||
| Convertible promissory note – related party, fair value | ||||||||||||
| Related Party Fair Value | ||||||||||||
| Total convertible promissory note – related party, fair value | ||||||||||||
| Convertible promissory note – related party, par value | ||||||||||||
| Related Party Par Value | ||||||||||||
| Total convertible promissory note – related party, par value | ||||||||||||
| Accrued expenses | ||||||||||||
| Total current liabilities | ||||||||||||
| Derivative liabilities | ||||||||||||
| Deferred underwriting commissions in connection with the initial public offering | ||||||||||||
| Total Liabilities | ||||||||||||
| Class A ordinary shares subject to possible redemption; $0.0001 par value; 1,578,648 and 2,111,794 shares at redemption value of approximately $11.17 and $10.95 per share as of June 30, 2024 and December 31, 2023, respectively | ||||||||||||
| Class A Ordinary Shares | ||||||||||||
| Total class A ordinary shares subject to possible redemption; $0.0001 par value; 1,578,648 and 2,111,794 shares at redemption value of approximately $11.17 and $10.95 per share as of June 30, 2024 and December 31, 2023, respectively | ||||||||||||
| Shareholders’ Deficit: | ||||||||||||
| Preference shares, $0.0001 par value; 5,000,000 shares authorized; 0 shares issued and outstanding as of June 30, 2024 and December 31, 2023 | ||||||||||||
| Ordinary shares | ||||||||||||
| Class A Ordinary Shares | ||||||||||||
| Class B Ordinary Shares | ||||||||||||
| Total ordinary shares | ||||||||||||
| Class B ordinary shares, $0.00009 par value; 50,000,000 shares authorized; 10,000,000 shares issued and outstanding as of June 30, 2023 and December 31, 2022 | ||||||||||||
| Additional paid-in capital | ||||||||||||
| Accumulated deficit | ||||||||||||
| Shareholders’ deficit | ||||||||||||
| Class B Ordinary Shares | ||||||||||||
| Total shareholders’ deficit | ||||||||||||
| Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit |
Loading...
